Tiedemann Advisors’s Shockwave Medical, Inc. Common Stock SWAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
$2.82M Sell
14,166
-17
-0.1% -$4.02K 0.12% 66
2023
Q2
$4.05M Buy
14,183
+17
+0.1% +$4.72K 0.17% 55
2023
Q1
$3.07M Hold
14,166
0.14% 60
2022
Q4
$2.91M Hold
14,166
0.14% 61
2022
Q3
$3.94M Hold
14,166
0.24% 46
2022
Q2
$2.71M Hold
14,166
0.2% 59
2022
Q1
$2.94M Hold
14,166
0.15% 69
2021
Q4
$2.53M Hold
14,166
0.12% 79
2021
Q3
$2.92M Hold
14,166
0.16% 70
2021
Q2
$2.69M Hold
14,166
0.11% 92
2021
Q1
$1.84M Hold
14,166
0.08% 108
2020
Q4
$1.47M Sell
14,166
-10,461
-42% -$906K 0.07% 121
2020
Q3
$1.87M Buy
+24,627
New +$1.4M 0.09% 132

Other funds holding SWAV

Tiedemann Advisors's SWAV Position: Q3 2023 in Review

Tiedemann Advisors reduced its Shockwave Medical, Inc. Common Stock (SWAV) stake by 0.12% in Q3 2023, selling an estimated $4.02K and leaving 14,166 shares worth $2.82M. The position accounts for 0.12% of the portfolio, ranked #66.

Tiedemann Advisors first reported a position in SWAV in Q3 2020 and has held it in 13 quarters since. The position peaked at $4.05M in Q2 2023. 412 funds tracked by Wall St. Rank hold SWAV as of Q3 2023.

  • Tiedemann Advisors held 14,166 shares of Shockwave Medical, Inc. Common Stock worth $2.82M as of Q3 2023.
  • Tiedemann Advisors sold 17 Shockwave Medical, Inc. Common Stock shares in Q3 2023, an estimated $4.02K.
  • Shockwave Medical, Inc. Common Stock made up 0.12% of Tiedemann Advisors's portfolio in Q3 2023, its #66 holding.
  • Tiedemann Advisors first reported a position in Shockwave Medical, Inc. Common Stock in Q3 2020 and has held it in 13 quarters since.
  • Tiedemann Advisors's Shockwave Medical, Inc. Common Stock position peaked at $4.05M in Q2 2023.
  • 412 funds tracked by Wall St. Rank held Shockwave Medical, Inc. Common Stock as of Q3 2023.

Based on Tiedemann Advisors's 13F filing for Q3 2023, filed 14 Nov 2023.